Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. (Q40805152)
Jump to navigation
Jump to search
scientific article published on May 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. |
scientific article published on May 2001 |
Statements
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer (English)
K C Bible
L C Hartmann
V Shridhar
J Staub
R Avula
Y K Lee
H Huang